Skip to Main Navigation Skip to Page Content

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Trimethylphosphate: Target Organs and Levels of Evidence for TR-081

Bioassay of Trimethylphosphate for Possible Carcinogenicity (CASRN 512-56-1)

Chemical (Study Title) CASRN	Peer Review Date	Route/Exposure Levels	Study Laboratory
Trimethylphosphate 512-56-1	03/06/1978	Gavage R: 0,50,100, M: 0,250,500 MG/KG/50 PER GROUP	Litton Bionetics, Inc.

Levels of Evidence

Male Rats: Positive

Type	Organ/Tissue (Lesion)
Neoplastic Lesions	Subcutaneous Tissue: (FIBROMA)

Female Rats: Negative

Male Mice: Negative

Female Mice: Positive

Type	Organ/Tissue (Lesion)
Neoplastic Lesions	Uterus/Cervix: (ADENOCARCINOMA)